Baseline Characteristics (N = 296)
| Characteristic | Intervention Group (n = 160) | Usual Care Group (n = 136) |
|---|---|---|
| Female, No. (%) | 107 (66.9) | 90 (66.2) |
| Age, mean (SD), y | 67.3 (9.0) | 67.5 (11.5) |
| Age at leaving school, mean (SD), y | 16.2 (1.2) | 16.1 (1.1) |
| Time since diagnosis, mean (SD), y | 6.5 (7.8) | 8.2 (11.3) |
| VSS-SF scores, median (IQR)a | ||
| Total score | 14 (8–22) | 13 (7–22) |
| Vertigo subscale score | 8 (5–13) | 8 (5–12) |
| Autonomic symptoms subscale score | 5 (2–9) | 5 (2–8) |
| DHI score, median (IQR)b | 32 (22–48) | 32 (20–55) |
| HADS scores, median (IQR)c | ||
| Anxiety score | 7 (4–10) | 6 (4–10) |
| Depression score | 4 (2–6) | 4 (2–7) |
DHI = Dizziness Handicap Inventory; IQR = interquartile range; VSS-SF = Vertigo Symptoms Scale–Short Form; HADS = Hospital Anxiety and Depression Scale.
↵a Higher scores indicate higher levels of dizziness. Ranges of scores in this trial: total score: 0–48; vertigo subscale score: 0–32; autonomic symptoms subscale score: 0–25.
↵b Higher scores indicate greater dizziness-related disability. Range of scores in this trial: 0–96.
↵c Higher scores indicate higher levels of anxiety and depression. Ranges of scores in this trial: anxiety score: 0–20; depression score: 0–20.